Concepedia

Sankar Jagadeeshan

SJ

Statistics

Publications

19

Citations

712

H-Index

15

Active since

2009

Affiliations

Rajiv Gandhi Centre for Biotechnology(Current)

Indian Institute of Technology Madras

Sri Ramachandra Institute of Higher Education and Research

Ben-Gurion University of the Negev

University of Madras

Sankar Jagadeeshan is an author at Rajiv Gandhi Centre for Biotechnology specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2009–2023

19

Publications

19

Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGA

GS Vinod Kumar, Lekha Nair, Sankar Jagadeeshan et al. · International Journal of Nanomedicine · 2011 · 140 citations · Full text

, , +17

MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer

Manu Prasad, Jonathan Zorea, Sankar Jagadeeshan et al. · Journal for ImmunoTherapy of Cancer · 2022 · 69 citations · Full text

, , +17

TGF-Beta-Activated Cancer-Associated Fibroblasts Limit Cetuximab Efficacy in Preclinical Models of Head and Neck Cancer

Ksenia M. Yegodayev, Ofra Novoplansky, Artemiy Golden et al. · Cancers · 2020 · 56 citations · Full text

, , +17

Transcriptional regulation of fibronectin by p21-activated kinase-1 modulates pancreatic tumorigenesis

Sankar Jagadeeshan, Y R Krishnamoorthy, Mahak Singhal et al. · Oncogene · 2014 · 55 citations

, , +14

P21-activated kinase 1 (Pak1) signaling influences therapeutic outcome in pancreatic cancer

Sankar Jagadeeshan, Anirudh Subramanian, Shilpa Tentu et al. · Annals of Oncology · 2016 · 53 citations · Full text

, , +11

1–5 of 19